Nivolumab With Vismodegib in Patients With Basal Cell Nevus Syndrome

NCT03767439 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Loss of funding

Conditions

Basal Cell Nevus Syndrome

Interventions

DRUG: Vismodegib
DRUG: Nivolumab
DRUG: Ipilimumab

Sponsor

Columbia University